Trials / Conditions / Myelomatosis
Myelomatosis
4 registered clinical trials studyying Myelomatosis.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | Study of BMF-219, a Covalent Menin Inhibitor, in Adult Patients With AML, ALL (With KMT2A/ MLL1r, NPM1 Mutatio NCT05153330 | Biomea Fusion Inc. | Phase 1 |
| Active Not Recruiting | Study of Selinexor Plus DRd for Newly Diagnosed Multiple Myeloma NCT04782687 | US Oncology Research | Phase 2 |
| Completed | MLN9708 (Ixazomib) in Combination With Panobinostat and Dexamethasone in Multiple Myeloma NCT02057640 | Jason Valent | Phase 1 / Phase 2 |
| Terminated | Th1/Tc1 Immunotherapy Following Stem Cell Transplantation in Multiple Myeloma NCT01239368 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |